Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib plus carboplatin and paclitaxel in BRCA-associated HER2-negative advanced breast cancer
2014-000345-70Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Veliparib + carboplatin + paclitaxel with Placebo + carboplatin + paclitaxel (2 arms). Primary endpoint: Progression-free survival. Started May 2014; status: completed.
02
Drugs
veliparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2014-000345-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000345-70.